Premarket Decliner
TIL Instil Bio24.61+8.39+51.7%
Premarket:19.92-4.69 (-19.1%)
Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago
Globe NewswireFri, 23-May 7:00 AM
